Acceder Registro /

Antonio Manuel Lax Pérez

Buscador

Pérez-Martínez MT, Lacunza-Ruiz J, García de Lara J, Noguera-Velasco JA, Lax A, Hernández-Vicente Á, Asensio-López MC, Januzzi JL Jr, Ibañez B, Pascual-Figal DA. Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2018 Sep 18;72(12):1429-1430. doi: 10.1016/j.jacc.2018.06.062. PubMed PMID: 30213338.
AÑO: 2018; IF: 18.639
Asensio-Lopez MDC, Lax A, Fernandez Del Palacio MJ, Sassi Y, Hajjar RJ, Pascual-Figal DA. Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction. Transl Res. 2018 Sep;199:4-23. doi: 10.1016/j.trsl.2018.04.004. Epub 2018 Apr 23. PubMed PMID: 29753686.
AÑO: 2018; IF: 4.915
Pascual-Figal DA, Pérez-Martínez MT, Asensio-Lopez MC, Sanchez-Más J, García-García ME, Martinez CM, Lencina M, Jara R, Januzzi JL, Lax A. Pulmonary Production of Soluble ST2 in Heart Failure. Circ Heart Fail. 2018 Dec;11(12):e005488. doi: 10.1161/CIRCHEARTFAILURE.118.005488. PubMed PMID: 30562096.
AÑO: 2018; IF: 6.526
Sanchez-Mas J, Lax A, Asensio-Lopez MC, Lencina M, Fernandez-Del Palacio MJ, Soriano-Filiu A, de Boer RA, Pascual-Figal DA. Early Anti-inflammatory and Pro-angiogenic Myocardial Effects of Intravenous Serelaxin Infusion for 72 H in an Experimental Rat Model of Acute Myocardial Infarction. J Cardiovasc Transl Res. 2017 Dec;10(5-6):460-469. doi: 10.1007/s12265-017-9761-1. Epub 2017 Jul 17. PubMed PMID: 28718055.
AÑO: 2017; IF: 2.337
Asensio-López MC, Soler F, Pascual-Figal D, Fernández-Belda F, Lax A. Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes. PLoS One. 2017 Feb 28;12(2):e0172803. doi: 10.1371/journal.pone.0172803. eCollection 2017. PubMed PMID: 28245258; PubMed Central PMCID: PMC5330507.
AÑO: 2017; IF: 2.766

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R